Injectables Toolkit

Community-Based Access to Injectables | Subcutaneous DMPA (depo-subQ)

Around the world, use of injectable contraceptives is rising dramatically-- more than 40 million women worldwide currently rely on injectables. The increasing demand for injectable contraception challenges programs to expand access to and improve the quality of services. Expanding access to injectable contraceptives with high-quality services helps fulfill women’s right to contraceptive choice and contributes to sustainable family planning programs.

This Toolkit includes information about both progestin-only injectables and combined injectables for health policy makers, program managers, and service providers. Expanding access to and use of injectable contraceptives requires a holistic approach including:
  • Accurate information
  • Up-to-date policies and guidelines
  • Quality training, supervision, and services
  • Effective communication and marketing
  • Proper logistics

In addition, this Toolkit provides information on community-based access to injectables, an effective strategy for increasing access to injectable contraceptives. You can also learn more about Subcutaneous DMPA (depo-subQ)—a lower-dose formulation of DMPA that is injected under the skin rather than in the muscle.

If you have an experience or publication about the introduction or provision of injectables to share, we invite you to send a message through the feedback form. To find out if a resource has already been included in this Toolkit, visit the site map or type the title in the search box. Visit the About page for more detailed information about who selected the resources, a list of publishers, and other K4Health Toolkits.

Learn more about Hormonal Methods of Contraception. Take the Global Health eLearning course (registration required).


Toolkit last updated: April 19, 2018